Suppr超能文献

设计一个用于可互操作且符合通用数据保护条例的健康数据交换的分布式账本技术系统:血糖数据的一个用例

Designing a Distributed Ledger Technology System for Interoperable and General Data Protection Regulation-Compliant Health Data Exchange: A Use Case in Blood Glucose Data.

作者信息

Hawig David, Zhou Chao, Fuhrhop Sebastian, Fialho Andre S, Ramachandran Navin

机构信息

Pact Care BV, Amsterdam, Netherlands.

Centre for Health Informatics & Multiprofessional Education, University College London, London, United Kingdom.

出版信息

J Med Internet Res. 2019 Jun 14;21(6):e13665. doi: 10.2196/13665.

Abstract

BACKGROUND

Distributed ledger technology (DLT) holds great potential to improve health information exchange. However, the immutable and transparent character of this technology may conflict with data privacy regulations and data processing best practices.

OBJECTIVE

The aim of this paper is to develop a proof-of-concept system for immutable, interoperable, and General Data Protection Regulation (GDPR)-compliant exchange of blood glucose data.

METHODS

Given that there is no ideal design for a DLT-based patient-provider data exchange solution, we proposed two different variations for our proof-of-concept system. One design was based purely on the public IOTA distributed ledger (a directed acyclic graph-based DLT) and the second used the same public IOTA ledger in combination with a private InterPlanetary File System (IPFS) cluster. Both designs were assessed according to (1) data reversal risk, (2) data linkability risks, (3) processing time, (4) file size compatibility, and (5) overall system complexity.

RESULTS

The public IOTA design slightly increased the risk of personal data linkability, had an overall low processing time (requiring mean 6.1, SD 1.9 seconds to upload one blood glucose data sample into the DLT), and was relatively simple to implement. The combination of the public IOTA with a private IPFS cluster minimized both reversal and linkability risks, allowed for the exchange of large files (3 months of blood glucose data were uploaded into the DLT in mean 38.1, SD 13.4 seconds), but involved a relatively higher setup complexity.

CONCLUSIONS

For the specific use case of blood glucose explored in this study, both designs presented a suitable performance in enabling the interoperable exchange of data between patients and providers. Additionally, both systems were designed considering the latest guidelines on personal data processing, thereby maximizing the alignment with recent GDPR requirements. For future works, these results suggest that the conflict between DLT and data privacy regulations can be addressed if careful considerations are made regarding the use case and the design of the data exchange system.

摘要

背景

分布式账本技术(DLT)在改善健康信息交换方面具有巨大潜力。然而,该技术的不可变和透明特性可能与数据隐私法规及数据处理最佳实践相冲突。

目的

本文旨在开发一个概念验证系统,用于实现血糖数据的不可变、可互操作且符合通用数据保护条例(GDPR)的交换。

方法

鉴于基于DLT的患者 - 提供者数据交换解决方案尚无理想设计,我们为概念验证系统提出了两种不同变体。一种设计纯粹基于公共IOTA分布式账本(一种基于有向无环图的DLT),另一种则将相同的公共IOTA账本与私有星际文件系统(IPFS)集群结合使用。两种设计均根据以下方面进行评估:(1)数据反转风险;(2)数据可链接性风险;(3)处理时间;(4)文件大小兼容性;(5)整体系统复杂性。

结果

公共IOTA设计略微增加了个人数据可链接性的风险,整体处理时间较短(将一个血糖数据样本上传到DLT平均需要6.1秒,标准差为1.9秒),且实施相对简单。公共IOTA与私有IPFS集群的组合将反转和可链接性风险降至最低,允许交换大文件(3个月的血糖数据平均38.1秒上传到DLT,标准差为13.4秒),但设置复杂性相对较高。

结论

对于本研究中探索的血糖特定用例,两种设计在实现患者与提供者之间的数据互操作交换方面均表现出合适的性能。此外,两个系统在设计时均考虑了个人数据处理的最新指南,从而最大程度地符合了GDPR的最新要求。对于未来的工作,这些结果表明,如果在使用案例和数据交换系统设计方面进行仔细考虑,DLT与数据隐私法规之间的冲突是可以解决的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fc9/6595943/152266886e41/jmir_v21i6e13665_fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验